185 related articles for article (PubMed ID: 27301873)
21. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
22. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
Zhang L; He Y; Ma G; Song C; Sun H
Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
[TBL] [Abstract][Full Text] [Related]
24. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
26. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.
Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X
J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492
[TBL] [Abstract][Full Text] [Related]
27. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
28. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
Ouahab A; Shao C; Shen Y; Tu J
Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
32. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
33. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
34. Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles.
Zheng J; Wan Y; Elhissi A; Zhang Z; Sun X
Pharm Res; 2014 Aug; 31(8):2220-33. PubMed ID: 24595496
[TBL] [Abstract][Full Text] [Related]
35. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.
He G; Ma LL; Pan J; Venkatraman S
Int J Pharm; 2007 Apr; 334(1-2):48-55. PubMed ID: 17116377
[TBL] [Abstract][Full Text] [Related]
36. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability.
Huang ZG; Lv FM; Wang J; Cao SJ; Liu ZP; Liu Y; Lu WY
Int J Pharm; 2019 Feb; 556():217-225. PubMed ID: 30557679
[TBL] [Abstract][Full Text] [Related]
37. Graphene oxide nanosheets conjugated PEG-Glu-Lys-Glu copolymer drug delivery system improves drug-loading rates and enables reduction-sensitive drug release and drug tracking.
Xu Q; Chen H; Zhu J; Li X; Yang J; Deng X; Yuan Q
J Biomater Sci Polym Ed; 2024 Feb; 35(3):330-344. PubMed ID: 38032009
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
[TBL] [Abstract][Full Text] [Related]
40. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]